TrialJournal of clinical and experimental hematopathology : JCEH2022

A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.

Ken Ohmachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.